Different faces of resistant hypertension in obesity
BACKGROUND: The aim was to conduct a comparative assessment between pseudo-resistant (due to different causes) and true resistant hypertension (RH) in obesity.
Anna Shalimova
doaj +5 more sources
Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care [PDF]
BackgroundTo confirm treatment-resistant hypertension (TRH), ambulatory blood pressure measurement (ABPM) must exclude white-coat hypertension (WCH), three or more medications should be prescribed at the optimal doses tolerated, and non-adherence and lifestyle should be examined.
Hayes, Peter +8 more
openaire +5 more sources
Resistant arterial hypertension: is it really so or have we missed something?
This publication discusses the relevance of the problem of blood pressure control in patients with resistance to drug therapy in real clinical practice. Data on the prevalence of true resistant arterial hypertension and clinical features of patients are ...
V. A. Ionin
doaj +1 more source
Clinical and epidemiological characteristics resistant hypertension in the practice of family doctor
Busel S.V. Clinical and epidemiological characteristics resistant hypertension in the practice of family doctor. Journal of Education, Health and Sport. 2016;6(11):702-714. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.225448 http://ojs.ukw.edu.
S. V. Busel
doaj +3 more sources
Efficacy and Safety of Spironolactone in the Treatment of Resistant Hypertension:a Meta-analysis [PDF]
BackgroundAs a special type of hypertension, resistant hypertension has complex etiology, is difficult to treat, and more likely to lead to target organ damage.
ZHANG Ping, ZOU Jing, GAO Cunzhou, WU Aiping, LI Rongshan
doaj +1 more source
Voloshyna O., Zbitnieva V., Busel S., Chaika A., Samorukova V., Dychko T. The role of additional correction methods of insufficient adherence to treatment for effective blood pressure control in patients with resistant arterial hypertension.
O. Voloshyna +5 more
doaj +3 more sources
Prevalence of White Coat Effect in Patients with Pseudo-resistant Hypertension
Introduction: The prevalence of white coat effect (WCE) in patients with pseudo-resistant hypertension is not established locally. WCE may result in unwarranted intensification of therapy, leading to increased health costs, drug adverse effects, and decreased adherence to prescribed treatment.
YEO Leh Siang +10 more
openaire +2 more sources
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. [PDF]
Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis.
Matson, M +31 more
core +1 more source
Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2:protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension [PDF]
INTRODUCTION: Resistant hypertension is inadequately controlled blood pressure (BP) despite treatment with at least three BP-lowering drugs. A popular hypothesis is that resistant hypertension is due to excessive Na(+)-retention, and that 'further ...
Williams, B +25 more
core +1 more source
Background: Resistant hypertension is a common medical challenge facing clinicians and specialists. Although, the prevalence is currently unknown but various clinical trials have suggested that this problem is not rare.
Ofulue, OO +6 more
core +1 more source

